<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="/xsl/rss2.xsl"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
    <channel>
        <title>Merck Sharp &amp; Dohme Corp. v. Anchen Pharmaceuticals, Inc., et al. :: Justia Dockets &amp; Filings</title>
        <link>https://dockets.justia.com/docket/delaware/dedce/1:2019cv00311/67784</link>
        <atom:link href="https://dockets.justia.com/docket/delaware/dedce/1:2019cv00311/67784/feed" rel="self" type="application/rss+xml" />
        <pubDate>Mon, 09 Nov 2026 15:54:19 -0800</pubDate>
        <lastBuildDate>Mon, 09 Nov 2026 15:54:19 -0800</lastBuildDate>
        <generator>Justia Dockets &amp; Filings</generator>
        <copyright>Copyright 2026 Justia Inc</copyright>
        <description>Merck Sharp &amp; Dohme Corp. v. Anchen Pharmaceuticals, Inc., et al. - Docket Entries - Showing 1 through 12</description>
                                    <item>
        <title>
                            <![CDATA[Document 12]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #9 Answer to Complaint, and Counterclaims, by Merck Sharp & Dohme Corp..(Silver, Daniel) Modified on 3/29/2019 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660565</guid>
                <pubDate>
            Thu, 28 Mar 2019 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorneys David H. Silverstein, Aziz Burgy, and Christopher M. Gallo for Anchen Pharmaceuticals, Inc. and Par Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660564</guid>
                <pubDate>
            Wed, 13 Mar 2019 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney David H. Silverstein, Aziz Burgy, and Christopher M. Gallo, filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/12/2019. (nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660563</guid>
                <pubDate>
            Tue, 12 Mar 2019 00:00:00 -0700
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660562</guid>
                <pubDate>
            Fri, 08 Mar 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660561</guid>
                <pubDate>
            Fri, 08 Mar 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 11]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney David H. Silverstein, Aziz Burgy, and Christopher M. Gallo - filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Fineman, Steven) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660560</guid>
                <pubDate>
            Thu, 07 Mar 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 10]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Par Pharmaceuticals, Inc.; Corporate Parent Par Pharmaceutical Inc. for Anchen Pharmaceuticals, Inc. filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Fineman, Steven) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660559</guid>
                <pubDate>
            Thu, 07 Mar 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 9]]>
                    </title>
                <description>
            <![CDATA[
                ANSWER to #1 Complaint, , COUNTERCLAIM against Merck Sharp & Dohme Corp. by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Fineman, Steven) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660558</guid>
                <pubDate>
            Thu, 07 Mar 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660557</guid>
                <pubDate>
            Thu, 07 Mar 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 8]]>
                    </title>
                <description>
            <![CDATA[
                DECLARATION of Mailing regarding service on Par Pharmaceutical, Inc. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660556</guid>
                <pubDate>
            Mon, 25 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 7]]>
                    </title>
                <description>
            <![CDATA[
                SUMMONS Returned Executed by Merck Sharp & Dohme Corp.. Anchen Pharmaceuticals, Inc. served on 2/14/2019, answer due 3/7/2019. (Silver, Daniel) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660555</guid>
                <pubDate>
            Mon, 25 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                SO ORDERED, re (6 in 19-cv-321-RGA, 6 in 19-cv-318-RGA, 6 in 19-cv-312-RGA, 6 in 19-cv-314-RGA, 6 in 19-cv-310-RGA, 6 in 19-cv-316-RGA, 6 in 19-cv-313-RGA, 6 in 19-cv-320-RGA, 6 in 19-cv-347-RGA, 6 in 1:19-cv-00319-RGA, 6 in 19-cv-317-RGA, 6 in 19-cv-311-RGA, 6 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jinyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/22/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660554</guid>
                <pubDate>
            Fri, 22 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00310-UNA et al.(bkb) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660553</guid>
                <pubDate>
            Thu, 21 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 6]]>
                    </title>
                <description>
            <![CDATA[
                MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660552</guid>
                <pubDate>
            Thu, 21 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Docket Entry]]>
                    </title>
                <description>
            <![CDATA[
                Summons Issued with Magistrate Consent Notice attached as to Anchen Pharmaceuticals, Inc. on 2/14/2019; Par Pharmaceuticals, Inc. on 2/14/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_3660551</guid>
                <pubDate>
            Thu, 14 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 5]]>
                    </title>
                <description>
            <![CDATA[
                Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (ddp) . 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_2878997</guid>
                <pubDate>
            Wed, 13 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 4]]>
                    </title>
                <description>
            <![CDATA[
                Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_2878996</guid>
                <pubDate>
            Wed, 13 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 3]]>
                    </title>
                <description>
            <![CDATA[
                Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/13/12 and 10/22/12. Date of Expiration of Patent: 11/24/26. (ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_2878995</guid>
                <pubDate>
            Wed, 13 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 2]]>
                    </title>
                <description>
            <![CDATA[
                Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_2878994</guid>
                <pubDate>
            Wed, 13 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                        <item>
        <title>
                            <![CDATA[Document 1]]>
                    </title>
                <description>
            <![CDATA[
                COMPLAINT filed against Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2569815.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(ddp) 
            ]]>
        </description>
                    <guid isPermaLink="false">https://dockets.justia.com#entry_2878993</guid>
                <pubDate>
            Wed, 13 Feb 2019 00:00:00 -0800
        </pubDate>
    </item>
                </channel>
</rss>
